Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma after 1 systemic treatment when a stem cell transplant is unsuitable (terminated appraisal)
Technology appraisal
Reference number: TA1083
Published:
Timelines for this appraisal are to be confirmed. Further information regarding the scheduling of this appraisal will be available in due course.